Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Poly MedicureNSE:POLYMED -0.67%99 Net Current Asset Value is ₹111.42 as of Mar. 2026, which is 100% below its 10-year median of 19.41. GuruFocus rates NSE:POLYMED with a GF Score™ of 99/100 and a GF Value™ of ₹2,366.81 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 564 Medical Devices & Instruments companies, Poly Medicure ranks worse than 81.74% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Poly Medicure's net current asset value per share for the quarter that ended in Mar. 2026 was ₹111.42.
The historical rank and industry rank for Poly Medicure's Net Current Asset Value or its related term are showing as below:
NSE:POLYMED'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 10.69 Med: 19.41 Max: 123.17
Current: 14.99
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Poly Medicure was 123.17. The lowest was 10.69. And the median was 19.41.
NSE:POLYMED's Price-to-Net-Current-Asset-Value is ranked worse than 81.74% of 564
companies
in the Medical Devices & Instruments industry
Industry Median: 4.905
vs NSE:POLYMED: 14.99
Poly Medicure (NSE:POLYMED) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Poly Medicure Net Current Asset Value Related Terms
Poly Medicure Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Poly Medicure's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:POLYMED vs ISRG, BDX, MDLN: Net Current Asset Value Comparison
For the Medical Instruments & Supplies subindustry, Poly Medicure's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Poly Medicure Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Poly Medicure's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of ₹111.42 mean?
Poly Medicure (NSE:POLYMED) has a Net Current Asset Value of ₹111.42 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Poly Medicure and its competitors. This is 474% above median its historical median of 19.41. Over the past decade, Poly Medicure's Net Current Asset Value has ranged from 10.69 to 123.17. According to the industry distribution chart, Poly Medicure ranks #461 out of 564 companies in the Medical Devices & Instruments industry, placing it in the top 81.7%.
Is Poly Medicure's Net Current Asset Value too high?
Poly Medicure's current Net Current Asset Value of ₹111.42 is 474% above median its 10-year median of 19.41. Over the past 10 years, this metric has ranged from a low of 10.69 to a high of 123.17. Based on the distribution chart, Poly Medicure ranks #461 out of 564 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Poly Medicure has a GF Score™ of 99/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Poly Medicure's Net Current Asset Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Poly Medicure ranks #461 out of 564 companies for Net Current Asset Value. This places Poly Medicure in the lower half of its industry. The industry median Net Current Asset Value is 4.91. Historically, Poly Medicure's own Net Current Asset Value has ranged from 10.69 to 123.17 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.91, based on 564 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Poly Medicure and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poly Medicure's current Net Current Asset Value is ₹111.42, which is 474% above median its own 10-year median of 19.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poly Medicure stock overvalued right now?
Based on GuruFocus' analysis, Poly Medicure (NSE:POLYMED) is currently considered Possible Value Trap. The stock's GF Value™ is ₹2,366.81, compared to a current price of ₹1,667.20 — trading 29.6% below its estimated fair value. The current Net Current Asset Value is ₹111.42, which is 474% above median its 10-year median of 19.41. Poly Medicure's overall GF Score™ is 99/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Poly Medicure (NSE:POLYMED), the current Net Current Asset Value is ₹111.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Poly Medicure (NSE:POLYMED) Overvalued in 2026?
Based on GuruFocus' analysis, Poly Medicure stock appears to be undervalued.
The current stock price of ₹1,667.20 is trading 29.6% below its estimated GF Value™ of ₹2,366.81.
GuruFocus considers Poly Medicure to be Possible Value Trap.
Key valuation signals for NSE:POLYMED:
Net Current Asset Value: ₹111.42 (474% above median its 10-year median of 19.41)
GF Value™: ₹2,366.81 vs. price of ₹1,667.20 (29.6% below fair value)
No single metric tells the full story. See the NSE:POLYMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.
99GF Score
Get the complete analysis for NSE:POLYMED
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:POLYMED has been successfully added to your 
